370 related articles for article (PubMed ID: 16636212)
1. Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women.
Prince RL; Devine A; Dhaliwal SS; Dick IM
Arch Intern Med; 2006 Apr; 166(8):869-75. PubMed ID: 16636212
[TBL] [Abstract][Full Text] [Related]
2. Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial.
Cheung AM; Tile L; Cardew S; Pruthi S; Robbins J; Tomlinson G; Kapral MK; Khosla S; Majumdar S; Erlandson M; Scher J; Hu H; Demaras A; Lickley L; Bordeleau L; Elser C; Ingle J; Richardson H; Goss PE
Lancet Oncol; 2012 Mar; 13(3):275-84. PubMed ID: 22318095
[TBL] [Abstract][Full Text] [Related]
3. Calcium plus vitamin D supplementation and the risk of fractures.
Jackson RD; LaCroix AZ; Gass M; Wallace RB; Robbins J; Lewis CE; Bassford T; Beresford SA; Black HR; Blanchette P; Bonds DE; Brunner RL; Brzyski RG; Caan B; Cauley JA; Chlebowski RT; Cummings SR; Granek I; Hays J; Heiss G; Hendrix SL; Howard BV; Hsia J; Hubbell FA; Johnson KC; Judd H; Kotchen JM; Kuller LH; Langer RD; Lasser NL; Limacher MC; Ludlam S; Manson JE; Margolis KL; McGowan J; Ockene JK; O'Sullivan MJ; Phillips L; Prentice RL; Sarto GE; Stefanick ML; Van Horn L; Wactawski-Wende J; Whitlock E; Anderson GL; Assaf AR; Barad D;
N Engl J Med; 2006 Feb; 354(7):669-83. PubMed ID: 16481635
[TBL] [Abstract][Full Text] [Related]
4. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
[TBL] [Abstract][Full Text] [Related]
5. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older.
Dawson-Hughes B; Harris SS; Krall EA; Dallal GE
N Engl J Med; 1997 Sep; 337(10):670-6. PubMed ID: 9278463
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial.
Reid IR; Ames RW; Evans MC; Gamble GD; Sharpe SJ
Am J Med; 1995 Apr; 98(4):331-5. PubMed ID: 7709944
[TBL] [Abstract][Full Text] [Related]
7. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.
Liberman UA; Weiss SR; Bröll J; Minne HW; Quan H; Bell NH; Rodriguez-Portales J; Downs RW; Dequeker J; Favus M
N Engl J Med; 1995 Nov; 333(22):1437-43. PubMed ID: 7477143
[TBL] [Abstract][Full Text] [Related]
8. Reappraisal of Katsuragi calcium study, a prospective, double-blind, placebo-controlled study of the effect of active absorbable algal calcium (AAACa) on vertebral deformity and fracture.
Fujita T; Ohue M; Fujii Y; Miyauchi A; Takagi Y
J Bone Miner Metab; 2004; 22(1):32-8. PubMed ID: 14691684
[TBL] [Abstract][Full Text] [Related]
9. Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study.
Siris ES; Harris ST; Eastell R; Zanchetta JR; Goemaere S; Diez-Perez A; Stock JL; Song J; Qu Y; Kulkarni PM; Siddhanti SR; Wong M; Cummings SR;
J Bone Miner Res; 2005 Sep; 20(9):1514-24. PubMed ID: 16059623
[TBL] [Abstract][Full Text] [Related]
10. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women.
Dawson-Hughes B; Dallal GE; Krall EA; Sadowski L; Sahyoun N; Tannenbaum S
N Engl J Med; 1990 Sep; 323(13):878-83. PubMed ID: 2203964
[TBL] [Abstract][Full Text] [Related]
11. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
Greenspan SL; Parker RA; Ferguson L; Rosen HN; Maitland-Ramsey L; Karpf DB
J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515
[TBL] [Abstract][Full Text] [Related]
12. Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial.
Ensrud KE; Black DM; Palermo L; Bauer DC; Barrett-Connor E; Quandt SA; Thompson DE; Karpf DB
Arch Intern Med; 1997 Dec 8-22; 157(22):2617-24. PubMed ID: 9531231
[TBL] [Abstract][Full Text] [Related]
13. Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study.
Chapuy MC; Pamphile R; Paris E; Kempf C; Schlichting M; Arnaud S; Garnero P; Meunier PJ
Osteoporos Int; 2002 Mar; 13(3):257-64. PubMed ID: 11991447
[TBL] [Abstract][Full Text] [Related]
14. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.
Chesnut CH; Skag A; Christiansen C; Recker R; Stakkestad JA; Hoiseth A; Felsenberg D; Huss H; Gilbride J; Schimmer RC; Delmas PD;
J Bone Miner Res; 2004 Aug; 19(8):1241-9. PubMed ID: 15231010
[TBL] [Abstract][Full Text] [Related]
15. Clinical and laboratory safety of one year's use of a combination calcium + vitamin D tablet in ambulatory elderly women with vitamin D insufficiency: results of a multicenter, randomized, double-blind, placebo-controlled study.
Brazier M; Grados F; Kamel S; Mathieu M; Morel A; Maamer M; Sebert JL; Fardellone P
Clin Ther; 2005 Dec; 27(12):1885-93. PubMed ID: 16507374
[TBL] [Abstract][Full Text] [Related]
16. Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis: bone density, mass, and strength of the radius, and wrist fracture.
Simon JA; Recknor C; Moffett AH; Adachi JD; Franek E; Lewiecki EM; McClung MR; Mautalen CA; Ragi-Eis S; Nicholson GC; Muschitz C; Nuti R; Törring O; Wang A; Libanati C
Menopause; 2013 Feb; 20(2):130-7. PubMed ID: 23010883
[TBL] [Abstract][Full Text] [Related]
17. Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementation.
van Bodegraven AA; Bravenboer N; Witte BI; Dijkstra G; van der Woude CJ; Stokkers PC; Russel MG; Oldenburg B; Pierik M; Roos JC; van Hogezand RA; Dik VK; Oostlander AE; Netelenbos JC; van de Langerijt L; Hommes DW; Lips P;
Gut; 2014 Sep; 63(9):1424-30. PubMed ID: 24146170
[TBL] [Abstract][Full Text] [Related]
18. Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial.
Reginster JY; Felsenberg D; Boonen S; Diez-Perez A; Rizzoli R; Brandi ML; Spector TD; Brixen K; Goemaere S; Cormier C; Balogh A; Delmas PD; Meunier PJ
Arthritis Rheum; 2008 Jun; 58(6):1687-95. PubMed ID: 18512789
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of vitamin D3 supplementation in preventing fractures in elderly women: a meta-analysis.
Bergman GJ; Fan T; McFetridge JT; Sen SS
Curr Med Res Opin; 2010 May; 26(5):1193-201. PubMed ID: 20302551
[TBL] [Abstract][Full Text] [Related]
20. Discriminatory ability of quantitative ultrasound measurements is similar to dual-energy X-ray absorptiometry in a Brazilian women population with osteoporotic fracture.
Pinheiro MM; Castro CH; Frisoli A; Szejnfeld VL
Calcif Tissue Int; 2003 Dec; 73(6):555-64. PubMed ID: 14517710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
